文献速递烧伤创面修复

烧伤酶性清创中区域阻滞应用分析

An Analysis of Regional Blocks During Enzymatic Debridement of Burns.
PubMed 文献 · J Burn Care Res · 2025-01-01

单中心回顾性比较研究纳入2016年7月至2024年7月接受菠萝蛋白酶类酶制剂清创的47例烧伤患者,其中24例(51.1%)应用区域阻滞。区域阻滞组酶制剂应用时疼痛评分显著低于未阻滞组(4.5 vs 7,P = .003),但阿片类药物需求较基线的变化无差异。作者认为区域阻滞可能与较低疼痛评分相关,但需前瞻性研究。

要点

  • 区域阻滞组酶性清创时疼痛评分4.5,未阻滞组7,差异有统计学意义(P = .003)。
  • 两组阿片类药物需求较基线变化无差异,右美托咪定需求区域阻滞组0% vs 未阻滞组78.3%(P < .001)。
  • 作者认为区域阻滞可能减少酶性清创疼痛,但需前瞻性研究验证。

核心结论

  • 数据提示区域阻滞与接受菠萝蛋白酶类酶制剂治疗的烧伤患者较低疼痛评分相关,但未改变阿片类药物较基线的需求。
  • 区域阻滞可能是减少酶性清创疼痛的有效策略,但需前瞻性研究。

研究设计与样本

  • 单中心回顾性比较研究,评估2016年7月至2024年7月所有接受菠萝蛋白酶类酶制剂治疗的患者。
  • 共47例患者纳入分析,其中24例(51.1%)接受区域阻滞。
  • 连续变量采用Wilcoxon秩和检验,分类变量采用卡方独立性检验。

主要发现

  • 除区域阻滞组基线阿片类药物需求较低外,两组基线特征无显著差异。
  • 酶制剂应用期间疼痛评分区域阻滞组4.5 vs 未阻滞组7,区域阻滞组显著更低(P = .003)。
  • 阿片类药物需求较基线变化无差异;除右美托咪定需求外,辅助药物需求无差异。
  • 右美托咪定需求区域阻滞组0% vs 未阻滞组78.3%(P < .001)。

临床怎么用

  • 本研究中心的做法已从多模式镇痛策略转变为在应用菠萝蛋白酶类酶制剂前使用区域阻滞。
  • 欧洲共识指南推荐对接受酶性清创的孤立肢体行区域麻醉,北美尚未达成共识。
  • 作者认为区域阻滞可能是减少该人群酶性清创疼痛的有效策略,但需前瞻性研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anacaulase is a mixture of enzymes used for the breakdown of eschar in patients with deep partial- or full-thickness burns up to 20% of the body's surface area. European consensus guidelines recommend regional anesthesia of an isolated extremity undergoing enzymatic debridement, but no North American consensus has been reached. Our practice has shifted from a multimodal pain strategy to utilize regional blocks prior to the application of anacaulase. The purpose of this study was to determine whether the introduction of regional blocks improved pain control in patients receiving anacaulase therapy. This is a single-center retrospective comparative study evaluating all patients who received anacaulase from July 2016 to July 2024. Continuous data was evaluated via the Wilcoxon rank sum test and categorical data was evaluated via the chi-square test of independence. In the prespecified period, 47 patients received anacaulase and were included for analysis. Of the 47 patients, 24 (51.1%) underwent regional block. There were no significant differences in baseline characteristics except lower baseline opioid requirements in the regional block group. Pain scores during anacaulase application were significantly lower in patients that received regional blocks (4.5 vs 7, P = .003). There was no difference in change in opioid requirements or requirement of adjunct medications except for dexmedetomidine requirements (0% vs 78.3%, P < .001). Our data suggest that regional blocks were associated with lower pain scores in burn patients receiving anacaulase therapy but did not result in a change in opioid requirements from baseline. Regional blocks may be an effective strategy in this population to reduce pain from enzymatic debridement, but prospective studies would be warranted.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Chasen Z, Suarez J, Kurjatko A, et al. An Analysis of Regional Blocks During Enzymatic Debridement of Burns. J Burn Care Res. 2025. PMID: 40360287. doi:10.1093/jbcr/iraf084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。